UWM
DWTX

Urban Wealth Management’s Dogwood Therapeutics DWTX Stock Holding History

Urban Wealth Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$10K Buy
+98
New +$10.2K 0.03% 203

Other funds holding DWTX

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Urban Wealth Management's DWTX Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Dogwood Therapeutics (DWTX) in Q2 2022: 98 shares worth $10K. The stake represents 0.03% of the portfolio and ranks #203 among its holdings.

17 funds tracked by Wall St. Rank hold DWTX as of Q2 2022.

  • Urban Wealth Management held 98 shares of Dogwood Therapeutics worth $10K as of Q2 2022.
  • Dogwood Therapeutics was a new Urban Wealth Management position in Q2 2022.
  • Dogwood Therapeutics made up 0.03% of Urban Wealth Management's portfolio in Q2 2022, its #203 holding.
  • 17 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.